Fei Mao Selected Research

Infections

3/2024	Drug Repurposing of ACT001 to Discover Novel Promising Sulfide Prodrugs with Improved Safety and Potent Activity for Neutrophil-Mediated Antifungal Immunotherapy.
6/2022	Novel niclosamide-derived adjuvants elevating the efficacy of polymyxin B against MDR Pseudomonas aeruginosa DK2.
1/2020	Targeting virulence factors as an antimicrobial approach: Pigment inhibitors.
10/2017	Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-Resistant, Linezolid-Resistant, and Vancomycin-Intermediate Staphylococcus aureus Infections in Vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fei Mao Research Topics

Disease

43	Neoplasms (Cancer) 02/2024 - 07/2010
16	Alzheimer Disease (Alzheimer's Disease) 02/2022 - 07/2012
14	Inflammation (Inflammations) 11/2023 - 06/2015
14	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2023 - 01/2017
12	Stomach Neoplasms (Stomach Cancer) 12/2023 - 06/2009
10	Carcinogenesis 12/2023 - 06/2009
7	Colitis 09/2023 - 01/2017
7	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2015
6	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 10/2018
5	Endometrial Neoplasms (Endometrial Cancer) 02/2024 - 01/2020
5	Urinary Bladder Neoplasms (Bladder Cancer) 08/2020 - 12/2017
5	Neoplasm Metastasis (Metastasis) 07/2020 - 12/2017
5	Cognitive Dysfunction 01/2019 - 01/2018
4	Infections 03/2024 - 10/2017
4	Type 2 Diabetes Mellitus (MODY) 10/2020 - 01/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 01/2020
3	Fibrosis (Cirrhosis) 11/2023 - 01/2022
3	Melanoma (Melanoma, Malignant) 03/2023 - 01/2021
3	Malaria 10/2022 - 12/2017
3	Body Weight (Weight, Body) 01/2022 - 01/2019
3	Ischemic Stroke 03/2020 - 10/2019
3	Peripheral Nervous System Diseases (PNS Diseases) 06/2019 - 01/2017
3	Acute Kidney Injury (Acute Renal Failure) 01/2018 - 10/2016
2	Lung Neoplasms (Lung Cancer) 02/2024 - 01/2021
2	Breast Neoplasms (Breast Cancer) 11/2023 - 12/2017
2	Hypoxia (Hypoxemia) 01/2023 - 06/2014
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2022
2	Amnesia (Dissociative Amnesia) 12/2017 - 09/2016
2	Colitis-Associated Neoplasms 09/2015 - 06/2015
2	Rheumatoid Arthritis 07/2015 - 04/2009
2	Colonic Neoplasms (Colon Cancer) 06/2015 - 06/2014

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 02/2024 - 09/2009
9	Biomarkers (Surrogate Marker)IBA 02/2024 - 06/2009
8	MicroRNAs (MicroRNA)IBA 11/2023 - 03/2016
6	Therapeutic UsesIBA 09/2022 - 01/2019
6	AntioxidantsIBA 01/2020 - 10/2012
6	Scopolamine (Hyoscine)FDA Link 01/2019 - 09/2016
5	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2017
5	AcetylcholinesteraseIBA 01/2019 - 12/2015
5	Tacrine (Cognex)FDA Link 01/2018 - 10/2012
4	Long Noncoding RNAIBA 12/2023 - 11/2018
4	LipidsIBA 11/2023 - 06/2015
4	ResveratrolIBA 09/2023 - 08/2014
4	Dextran SulfateIBA 09/2022 - 01/2017
4	LigandsIBA 02/2022 - 10/2012
4	Messenger RNA (mRNA)IBA 01/2022 - 09/2009
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
4	LipopolysaccharidesIBA 01/2021 - 01/2016
4	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 04/2013
3	Chlorpromazine (Thorazine)FDA Link 02/2024 - 01/2021
3	CollagenIBA 01/2023 - 03/2010
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 06/2009
3	CaspasesIBA 09/2022 - 12/2017
3	Vilazodone HydrochlorideIBA 02/2022 - 12/2017
3	CytokinesIBA 01/2022 - 04/2009
3	ChemokinesIBA 08/2021 - 08/2019
3	Circular RNAIBA 01/2021 - 01/2020
3	matrigelIBA 10/2020 - 01/2018
3	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2020 - 01/2018
3	CateninsIBA 01/2020 - 03/2016
3	NAD (NADH)IBA 06/2019 - 01/2017
3	MetalsIBA 09/2018 - 10/2012
3	Phosphotransferases (Kinase)IBA 01/2017 - 01/2012
2	UbiquitinIBA 01/2024 - 01/2018
2	Sunitinib (Sutent)FDA Link 11/2023 - 01/2023
2	SaltsIBA 01/2023 - 01/2022
2	Progesterone FDA LinkGeneric 10/2022 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 09/2022 - 06/2015
2	AzoxymethaneIBA 01/2022 - 01/2017
2	Dextrans (Dextran)FDA Link 01/2022 - 01/2017
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2022
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2022 - 01/2017
2	EnzymesIBA 01/2021 - 10/2020
2	candesartanIBA 01/2021 - 01/2020
2	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 01/2020
2	nitazoxanide (NTZ)FDA Link 04/2020 - 10/2019
2	Ciclopirox (Loprox)FDA LinkGeneric 03/2020 - 01/2020
2	staphyloxanthinIBA 01/2020 - 10/2017
2	Amyloid (Amyloid Fibrils)IBA 10/2019 - 10/2012
2	diazonaphthalenedisulfonic acid (NDS)IBA 06/2019 - 01/2018
2	Oxidoreductases (Dehydrogenase)IBA 01/2019 - 01/2017
2	beta CateninIBA 01/2019 - 10/2018
2	Monoamine Oxidase (MAO)IBA 01/2019 - 10/2012
2	Vancomycin FDA LinkGeneric 02/2018 - 10/2017
2	Linezolid (Zyvox)FDA Link 02/2018 - 10/2017
2	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2018 - 01/2018
2	propargylamineIBA 01/2018 - 12/2015
2	Citric Acid (Citrate)FDA LinkGeneric 01/2018 - 01/2018
2	CopperIBA 01/2018 - 09/2016
2	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2018 - 01/2017
2	Tadalafil (Cialis)FDA Link 01/2018 - 01/2018
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2017 - 06/2015
2	Indicators and Reagents (Reagents)IBA 08/2017 - 10/2016
2	3,3'-diindolylmethane (diindolylmethane)IBA 01/2017 - 03/2016
2	ebselenIBA 05/2015 - 12/2013
2	Clioquinol (Vioform)FDA Link 10/2014 - 08/2014

Therapy/Procedure

23	Therapeutics 02/2024 - 07/2010
4	Immunotherapy 03/2024 - 01/2021
2	Drug Therapy (Chemotherapy) 02/2024 - 01/2024
2	Aftercare (After-Treatment) 02/2019 - 10/2016